• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

John Smith - Articles and news items

Lilly-Logo

FDA approves updated prescribing information for Tradjenta® (linagliptin) tablets

Industry news, News / 17 August 2012 / Eli Lilly and Company

Updated label also includes data on adult patients with type 2 diabetes…

Lilly-Logo

New Phase 3 data for Tradjenta® (linagliptin) tablets

Industry news, News / 24 May 2012 / Eli Lilly and Company

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced Phase 3 study results…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +